Americans are spending more than ever on pets, propelling the entire industry to new heights

0

NEW YORK, June 15, 2021 / PRNewswire / – Dogs have always been man’s best friend, but the amount of money pet owners spend on their four-legged friends has grown dramatically over the years. In fact, over the past 10 years, the amount Americans spent on their pets has more than doubled to a whopping $ 103.6 billion in 2020. Millennials, who are the largest group in the United States, spend significantly more on their pets than previous generations on pet food, grooming, veterinary care, pet insurance, and even box sets. monthly giveaways, propelling the entire industry to new heights. The rise in pet spending has boosted companies in the industry, including LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) (FRA: 5XS2), The Original Bark Co. (NYSE: BARK), Petmed Express Inc. (NASDAQ: PETS), Zoetis Inc. (NYSE: ZTS), and Aon PLC (NYSE: AON).

With the cost of pet care on the rise, there are several factors that should be considered for your furry friend. These include the basics such as food, shelter, nutritional supplements, hygiene, and routine check-ups with a veterinarian. LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) (FRA: 5XS2) is a molecular diagnostic company that develops molecular diagnostic systems for the detection of pathogens and genetic tests for other molecular markers for rapid on-site testing in various fields, including veterinary diagnostics. LexaGeneMiQLab for Veterinary Diagnostics is a genetic analyzer designed to perform real-time point-of-care veterinary diagnostic testing, allowing veterinarians to quickly diagnose and determine what caused your pet’s illness compared to conventional long-term practices. The MiQLab, which is equipped with a bacterial and AMR test, detects the seven most common bacterial pathogens as well as 13 different antimicrobial factors and returns the results in about two hours.

In May, LexaGene hired several experienced veterinary representatives to support the launch of their MiQLab in this lucrative market, where competition for the detection of pathogens in hospital settings is virtually non-existent. Less than a month after expanding their sales team, LexaGene announced two purchase orders for its MiQLab system and may have more after generating “multiple MiQLab sales leads from the ACVIM forum”, which the company participated in last week. The first purchase order came from Denver Animal Emergency, which has been using the system for several months as part of the early access program.

“We compared the accuracy of the MiQLab to the results generated by the culture and the concordance was so high that we found that we run MiQLab more often than we send samples for culture.” said dr. Andrew Pierce, owner and medical director of Denver Animal Emergency. “The MiQLab identifies not only the most common pathogens, but also many common antimicrobial resistance factors. Knowing this information soon after seeing the animal has boosted our confidence that our prescribed therapies will effectively treat the infection, even if it is resistant to some antibiotics. Our vets loved it so much and our customers are getting better care, so it was an easy decision to purchase the system. “

A week later, LexaGene ad closing a sale at the Alpine Veterinary Hospital, which provides a wide range of services including emergency and orthopedic surgeries in the Bay Area California.

“We are delighted that the Alpine Veterinary Hospital sees that the future of animal care begins with the MiQLab system”, mentionned LexaGene CEO and Founder, Dr. Jack regan. “We continue to gain momentum in the veterinary health arena as we generated several MiQLab sales leads through the ACVIM forum, which we attended last week, and through the hard work of our dedicated sales team. . “

Otherwise, LexaGene recently announced its partnership with Ethos Discovery to expand the test menu offerings that can be run on the MiQLab ™ system. Ethos Discovery, which was an early adopter of MiQLab technology due to test coverage included in LexaGene’s first validated panel, now wants to expand MiQLab use cases to help diagnose other diseases. .

Pet inventories continue to bolster sales revenue

The Original Bark Co. (NYSE: BARK) is a company known for its subscription service which includes dog food, toys and other dog products. The leading brand for dogs is a merger between specialist acquisition company Northern Star Acquisition Corp. and Barkbox Inc. With its subscription service, To bark serves more 1 million dogs on a monthly basis and is approximately valued at $ 1.6 billion. Continuing the trend of advanced pet care, the subscription service is another example of an innovative business among millennial pet owners.

Petmed Express Inc. (NASDAQ: PETS) recently announced its fourth quarter and full year results, showing an 18.4% increase in net income as well as a 9.7% increase in order sales. The president and CEO commented on the company’s unexpected success earlier this year and said the increase in demand for e-commerce was partly due to the global health crisis, but also predicts the need for care. important for pets.

Global animal health company, Zoetis Inc. (NYSE: ZTS), builds on its history of supporting animal keepers. The company also reported its 2020 sustainable development report and expressed its commitment $ 35 million over the past 5 years through its creation, the Zoetis Foundation. The foundation aims to advance opportunities for veterinarians and farmers.

For a pet owner, pet insurance can be a high cost to bear, but it is also crucial for them because it ensures that the animal is healthy and well cared for. Aon PLC (NYSE: AON), the world’s largest insurance broker with more than $ 30 billion in assets, is a majority owner of Healthy Paws, a leading U.S. insurer that was recently voted number one in America.

As the animal health industry continues to thrive, experts predict growth like never before. The market value is expected to reach figures twice as high as its present value in the next few years. In addition, companies like LexaGene Holdings produce innovative devices that will also be part of a veterinarian’s daily routine.

For more information on LexaGene Holdings, Click here.

Disclaimer: Microsmallcap.com (MSC) is the source for the article and content set forth above. References to an issuer other than the profiled issuer are intended only to identify industry participants and do not constitute an endorsement of an issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and information dissemination service provider, which distributes electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned in this document. The comments, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not in any way reflect the views or opinions of FNM. Readers of this article and its content agree that they cannot and will not seek to hold MSC and FNM accountable for the investment decisions of their readers or subscribers. MSC and FNM and their respective affiliates are a provider of financial marketing and information dissemination solutions and are NOT registered brokers / analysts / investment advisers, do not hold any investment license and may not sell, offer sell or offer to buy securities.

The article and content related to the profiled company represent the personal and subjective opinions of the author (MSC), and are subject to change at any time without notice. The information provided in the article and the content has been obtained from sources which the author considers reliable. However, the author (MSC) has not independently verified or investigated all of this information. None of the authors, MSC, FNM or any of their respective affiliates guarantees the accuracy or completeness of this information. This article and its contents are not and should not be construed as investment advice or as a recommendation regarding any particular title or course of action; Readers are strongly encouraged to speak with their own investment advisor and review all documents filed by the profiled issuer with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with investing in the securities of the profiled issuer, including, but not limited to the total loss of your investment. FNM has not been remunerated by any public company mentioned in this document to distribute this press release but has been remunerated twenty five hundred dollars by MSC, an unaffiliated third party to distribute this release on behalf of LexaGene Holdings

FNM DOES NOT HOLD ANY SHARES OF ANY COMPANY NAMED IN THIS PRESS RELEASE.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made in accordance with to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results or strategies and are usually preceded by words such as “may”, “future”, ” plan “or” planned “,” will “or” should “,” expected “,” anticipate “,” draft “,” possibly “or” planned “. You are cautioned that these statements are subject to a multitude of risks and uncertainties which could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ. substantially from those projected. in forward-looking statements due to various factors and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other documents filed by that company with the Securities and Exchange Commission. You should take these factors into account when evaluating the forward-looking statements included in this document and not place undue reliance on such statements. The forward-looking statements contained in this press release are made as of the date hereof, and MSC and FNM do not undertake to update such statements.

Media contact:
FN Media Group, LLC
[email protected]
+1(561)325-8757

SOURCE Microsmallcap.com

Leave A Reply

Your email address will not be published.